The use of CO2 laser in the treatment of oral white patches:: outcomes and factors affecting recurrence

被引:48
作者
Chandu, A
Smith, ACH
机构
[1] Univ Melbourne, Sch Dent Sci, Melbourne, Vic 3000, Australia
[2] Austin Hlth, Heidelberg, Vic, Australia
关键词
laser; leukoplakia; dysplasia; outcome; recurrence; oral;
D O I
10.1016/j.ijom.2004.10.003
中图分类号
R78 [口腔科学];
学科分类号
1003 [口腔医学];
摘要
Laser therapy has been a favoured treatment regime for oral leukoplakia since the mid 1980s. There is no information in the literature regarding factors affecting outcomes in patients with oral leukoplakia. Forty-three patients (mean age 60.3 +/- 13.6 years) with 73 primary oral leukoplakia were assessed for outcome and factors affecting survival. Dysplastic lesions were found in the majority of patients. The male to female ratio was 1.7:1 with 74% ex- or current smokers, 27% consuming alcohol and 31% continuing to smoke after treatment. The mean observation time was 47.2 +/- 28.2 months (range 2-102 months). Disease-free survival was 55.4% at 3 years that dropped to 33.9% after 5 years. The malignant transformation rate was 7.3%. No significant prognostic factors were found on univariate analysis but alcohol consumption (P = 0.034) and previous malignancy (P = 0.018) were found to be significant prognostic indicators using multivariate analysis. Continuation to smoke approached significance (P = 0.061). Similar disease-free survival and malignant transformation rates with minimal complications were found as compared to the literature. Recommendations for minimizing recurrence are presented. Long-term follow up and removal of aetiological factors, such as smoking and alcohol, are advised.
引用
收藏
页码:396 / 400
页数:5
相关论文
共 25 条
[1]
CHIESA F, 1990, ARCH OTOLARYNGOL, V116, P177
[2]
CHU FWK, 1988, LARYNGOSCOPE, V98, P125
[3]
CLAYMAN L, 1997, LASERS MAXILLOFACIAL, P19
[4]
USE OF THE CARBON-DIOXIDE LASER IN THE MANAGEMENT OF PREMALIGNANT LESIONS OF THE ORAL-MUCOSA [J].
FRAME, JW ;
DASGUPTA, AR ;
DALTON, GA ;
EVANS, PHR .
JOURNAL OF LARYNGOLOGY AND OTOLOGY, 1984, 98 (12) :1251-1260
[6]
Hashibe M, 2000, INT J CANCER, V88, P129, DOI 10.1002/1097-0215(20001001)88:1&lt
[7]
129::AID-IJC20&gt
[8]
3.0.CO
[9]
2-U
[10]
Hashibe M, 2000, CANCER EPIDEM BIOMAR, V9, P639